Neoadjuvant Chemotherapy Versus Adjuvant Chemotherapy for Very Low-Lying Clinical T3 Rectal Cancer: The NAIR Phase 2/3 Randomized Clinical TrialYuichiro Tsukada, Masaaki Ito, Fumihiko Fujita et al.|Annals of Surgery Open|2025Cited by 2
Neoadjuvant chemotherapy (NAC) followed by total mesorectal excision (TME) and adjuvant chemotherapy versus TME followed by adjuvant chemotherapy in very low-lying clinical (c) T3 rectal cancer (NAIR): A multicenter, randomized, open-label, phase 2/3 trial.Yuichiro Tsukada, Masaaki Ito, Yoshiyuki Kawashima et al.|Journal of Clinical Oncology|2023Cited by 1